Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group.
Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group.
Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215.
Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer.
Ahn JH, Park JM, Choi SB, Go J, Lee J, Kim JY, Park HS.
Breast Cancer Res Treat. 2023 Apr;198(3):405-412. doi: 10.1007/s10549-022-06760-8. Epub 2022 Nov 23.
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer.
Reimer T.
Breast. 2023 Feb;67:124-128. doi: 10.1016/j.breast.2023.01.002. Epub 2023 Jan 9.
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.
Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K.
Oncologist. 2020 Feb;25(2):e231-e242. doi: 10.1634/theoncologist.2019-0427. Epub 2019 Oct 14.
Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study.
Zhu T, Huang YH, Li W, Zhang YM, Lin YY, Cheng MY, Wu ZY, Ye GL, Lin Y, Wang K.
Int J Surg. 2023 Nov 1;109(11):3383-3394. doi: 10.1097/JS9.0000000000000621.
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis.
Ngai V, Tai JCJ, Taj S, Khanfar H, Sfakianakis E, Bakalis A, Baker R, Ahmed M.
Breast Cancer Res Treat. 2022 Sep;195(2):161-169. doi: 10.1007/s10549-022-06672-7. Epub 2022 Jul 21.
Axillary lymph node dissection.
Boullenois H, Peschaud F, Lupinacci RM.
J Visc Surg. 2023 Feb;160(1):55-59. doi: 10.1016/j.jviscsurg.2022.08.006. Epub 2022 Oct 1.
Evaluation of Axillary Lymph Node Marking with Magseed before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
Martínez M, Jiménez S, Guzmán F, Fernández M, Arizaga E, Sanz C.
Breast J. 2022 Jul 9;2022:6111907. doi: 10.1155/2022/6111907. eCollection 2022.
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF.
Ann Surg Oncol. 2023 Dec;30(13):8327-8334. doi: 10.1245/s10434-023-14245-1. Epub 2023 Sep 5.
